Before revision:  Both the single-drug and combination therapy policies obtained in training exhibit a 100\% success rate at suppressing simulated heterogeneous harmful cell growth and responding to diverse system fluctuations and perturbations within the alloted time and using conservative dosing.
After revision:  Both the single-drug and combination therapy policies that exhibit a 100\% success rate at suppressing simulated heterogeneous harmful cell growth and responding to diverse system fluctuations and perturbations within the alloted time and using conservative dosing.